myristic acid has been researched along with Vaccinia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cotter, CA; Faronato, M; Goldsmith, CS; Kallemeijn, WW; Moss, B; Ojeda, S; Priyamvada, L; Satheshkumar, PS; Solari, R; Tate, EW; Wilkins, K | 1 |
| Cohen, GH; Eisenberg, RJ; Foo, CH; Ponce-de-León, M; Saw, WT; Whitbeck, JC | 1 |
2 other study(ies) available for myristic acid and Vaccinia
| Article | Year |
|---|---|
Inhibition of vaccinia virus L1 N-myristoylation by the host N-myristoyltransferase inhibitor IMP-1088 generates non-infectious virions defective in cell entry.
Topics: Alkynes; Animals; Humans; Myristic Acid; Vaccinia; Vaccinia virus; Viral Proteins; Virion; Virus Internalization | 2022 |
The myristate moiety and amino terminus of vaccinia virus l1 constitute a bipartite functional region needed for entry.
Topics: Amino Acid Motifs; Amino Acid Sequence; Cell Line; Humans; Molecular Sequence Data; Myristic Acid; Sequence Alignment; Vaccinia; Vaccinia virus; Viral Envelope Proteins; Virus Internalization | 2012 |